Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Consistent weekly use as prescribed by your doctor is key to achieving the best results
Understanding these common reactions helps patients distinguish between expected, manageable symptoms and those requiring medical attention
You dont want to ruin the batch
3 minute read Summary Personal dosing (also known as microdosing) GLP-1 medications during menopause involves using sub-clinical doses to manage weight while minimizing side effects
Injection Site Reactions: Because its an injection, some local reactions can occur about 5% of users had injection site reactions such as slight pain, redness, or itching at the shot site
The most frequent gastrointestinal side effects include: Nausea and vomiting : Very common, typically most pronounced during dose escalation Diarrhoea : Common to very common, though usually mild to moderate Constipation : Can occur due to delayed gastric emptying and reduced gut motility Abdominal pain and discomfort : Common Dyspepsia and gastro-oesophageal reflux : May worsen in susceptible individuals Other important adverse effects include: Gallbladder disorders : Cholelithiasis and cholecystitis have been reported, particularly with weight loss Dehydration and acute kidney injury : May occur secondary to severe gastrointestinal symptoms Hypoglycaemia : Risk increases when used with insulin or sulfonylureas, which may require dose adjustment Current limited evidence does not suggest an increased risk of inflammatory bowel disease (IBD) flares with GLP-1 agonists, though more data are needed
US$ 27.21
US$ 21.21
US$ 22.78
